Michael Kramer

Michael Kramer

Michael Kramer is the Founder of Mott Capital Management. His unique investment philosophy centers on seeking investment opportunities that are influenced by everyday life activities, and by observing new trends and products that are popular or are trending towards popularity. Additionally, he devotes a significant part of his research to global macroeconomics and central bank policies impacting financial markets.

Kramer runs the Mott Capital Management actively managed long-only Thematic Growth Portfolio, which holds these stocks: AAPL, ACAD, ALKS, CELG, DEO, DIS, GOOGL, MA, MO, NFLX, NXPI, RTN, SWKS TSLA, UL, V, VOD and VZ.

Kramer began his career in high-risk trading environments, trading both US and international equities. His trading skills coupled with his comprehensive, financial analysis of public companies, have given him a unique perspective on investing, which stands out from analysts who simply look at top-line numbers. In addition to fundamental analysis, Kramer also incorporates technical and options market analysis into his research.

Kramer is a fundamental writer for Investopedia.com, analyzing stocks and market news that is helpful for everyday investors to make short and long-term investment decisions.

  1. Stocks

    Eli Lilly & Co. Surges on Strong FY'17 Guidance (LLY)

    Shares of the pharmaceutical company are spiking higher today after providing 2017 guidance that was ahead of expectations.
  2. Stocks

    Fed Raises Rates For First Time In A Year, Takes Hawkish Tone

    The FOMC has raised rates by 25 bps, as expected, to a range of 0.50-0.75%.
  3. Stocks

    Who Killed the Actelion/J&J Deal? (JNJ)

    J&J and Actelion have ended deal talks, new offer has yet to appear.
  4. Stocks

    WWE Shares Fall On Debt Offering (WWE)

    Shares of WWE are slumping by nearly 4% following a $200 million convertible debt deal.
  5. Stocks

    WWE: Low End of Subscriber Base is Growing (WWE)

    After the close WWE increased guidance on its total subscriber base.
  6. Stocks

    JNJ & PFE are Leading Healthcare Higher (JNJ, PFE)

    A positive article on Johnson & Johnson and a Pfizer dividend increase are boosting their shares, and the group higher.
  7. Stocks

    PFE Bounces, But Is It Just A Dead Cat? (PFE, XLV)

    Pfizer, along with Akili Interactive, reported positive data that could help with the detection of onset Alzheimer's disease.
  8. Stocks

    Lions Gate Closes on Starz Acquisition (LGF.A, LGF.B)

    Lionsgate and Starz announced the completion of their $4.4 billion merger yesterday.
  9. Stocks

    Allergan Jumps In Early Trading (AGN)

    Shares of AGN are surging by 4% following comments out of Citi and Credit Suisse.
  10. Stocks

    Broadcom Poised for Higher Highs (AVGO)

    The semiconductor solutions company reported strong results after the close yesterday. Analysts are following up with upgrades. ...
  11. Stocks

    AVGO Beats On Top & Bottom Line, Shares Up (AVGO)

    Broadcom beats analyst expectations for Q4 top and bottom line.
  12. Stocks

    Allergan Talks Strategy at Citi Conference (AGN)

    Brent Saunders, AGN's CEO had much to say about drug pricing and acquisition possibilities.
  13. Stocks

    Teva Gets Boost On CEO's Positive Comments (TEVA)

    Teva shares are up by about 3% following comments from the CEO at the Citi Global Healthcare Conference.
  14. Stocks

    PFE Lower After Record Fine From The UK (PFE)

    The company was fined for its unfair practices and pricing.
  15. Stocks

    Is Pandora Looking For Another Suitor? (P, SIRI)

    Pandora is moving higher on reports from CNBC that the company is looking outside of Sirius.